{"id":"W2588171532","doi":"10.1093/annonc/mdw373.54","title":"Clinical outcomes and dosing patterns of 2nd targeted therapy in metastatic renal carcinoma: a retrospective chart review in the EU","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Novartis Pharmaceuticals Canada","keywords":"Medicine; Pazopanib; Sunitinib; Sorafenib; Renal cell carcinoma; Axitinib; Hazard ratio; Internal medicine; Oncology; Targeted therapy; Proportional hazards model; Everolimus; Dosing; Progression-free survival; Temsirolimus; Cancer; Overall survival; Confidence interval; Hepatocellular carcinoma","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008626567,0.0001227328,0.000422194,0.001196598,0.0002920322,0.0008287525,0.0002594453,0.0003184206,0.0007781712],"category_scores_gemma":[0.002960072,0.0001625069,0.0004095887,0.002715818,0.0002974229,0.0005019849,0.0003914067,0.0002668906,0.00009204856],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008457413,"about_ca_system_score_gemma":0.000868741,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00629458,"about_ca_topic_score_gemma":0.004788647,"domain_scores_codex":[0.9988291,0.0002705865,0.0002879395,0.0002581533,0.0002118966,0.0001423277],"domain_scores_gemma":[0.9970872,0.0005639352,0.001777717,0.0001293231,0.0002650855,0.0001767697],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001344006,0.00002666877,0.9955681,0.00005940597,0.0000676283,0.0003757231,0.0001450349,0.00008612283,0.0001802689,0.00006636031,0.0002294787,0.003060852],"study_design_scores_gemma":[0.00000655507,0.00008130736,0.9968603,0.00004541368,0.0000484036,0.001112052,0.0005219399,0.0001579394,0.0002256273,0.00002542906,0.0009063734,0.000008738973],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954,0.002232496,0.0001704902,0.00009308715,0.000006811872,0.00001631609,0.001344691,0.000006047723,0.0007301364],"genre_scores_gemma":[0.9979387,0.0008479222,0.0001292303,0.00006340241,0.000005802171,0.000008641294,0.0009155468,0.000004576314,0.00008615165],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00629458,"threshold_uncertainty_score":0.0125159,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1593697071173639,"score_gpt":0.4342919707927113,"score_spread":0.2749222636753474,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}